# Study of Rasagiline in Patients With Amyotrophic Lateral Sclerosis

> **NCT01879241** · PHASE2 · COMPLETED · sponsor: **University of Ulm** · enrollment: 252 (actual)

## Conditions studied

- Amyotrophic Lateral Sclerosis

## Interventions

- **DRUG:** Rasagiline
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT01879241
- **Lead sponsor:** University of Ulm
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2013-06
- **Primary completion:** 2016-04
- **Final completion:** 2016-08
- **Target enrollment:** 252 (ACTUAL)
- **Last updated:** 2016-10-25


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01879241

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01879241, "Study of Rasagiline in Patients With Amyotrophic Lateral Sclerosis". Retrieved via AI Analytics 2026-05-27 from https://api.ai-analytics.org/clinical/NCT01879241. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*